Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Fyr Diagnostics, Medmira, Shimadzu.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ascendis, Immunicum.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Clene, Generex, Global Cancer Technology, Hoth, Moderna, Nugenerex, Tergus.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Axsome, Direct Biologics, Lexicon, Netris, Redhill.

Biopharmas raising money in public or private financings, including: Enveric, Ensysce, Helix, Hemostemix, Histogen, Immvira, Innocan, Neonmind.

New hires and promotions in the biopharma industry, including: Revive.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Visionquest, Zetroz Systems.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Lexagene.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 1health, Aprinoia Therapeutics, Aspero Medical, Assure Holdings, Biocept, Bionano Genomics, Cyduct Diagnostics, Dermtech, Diasorin Molecular, Icad, Immunoprecise Antibodies, Insilico Medicine, Neuro-Pro Monitoring, Olympus, Predictive Oncology, Qynapse, Theracell, Titan Medical, Veran Medical Technologies.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: MDCG posts guidance agenda for 2021; CPC comments on FDA’s skin biocompatibility draft.